Compound HSYA Alleviates Autism-Like Behaviors and Altered ADAM10 Expression in Mice
Bioengineer.org
A study found that the compound HSYA reduces autism-like behaviors and lowers ADAM10 protein expression in a mouse model of autism. ADAM10 was identified as a key gene involved in microglial function and neuroimmune communication, with structural simulations suggesting a direct interaction between HSYA and ADAM10. These findings highlight ADAM10 as a potential therapeutic target and demonstrate HSYA's potential in modulating autism-related molecular pathways.
All articles from 9 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.
Get this news by email
Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.